1. MARKETS
  2. SECTOR : CHEMICALS & PETROCHEMICALS
  3. INDUSTRY : MAJOR DIVERSIFIED CHEMICALS
  4. INNOSPEC INC
Innospec Inc
XNAS: IOSP
96.810.21(0.22%)
177.7K
XNAS Volume

XNAS 16 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Innospec Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Innospec Inc share price target, revenues, EPS, net income and more

Innospec Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Innospec Inc Jun-2026 Quarterly Revenue is $491 Million which is growth of 11.8% YoY.

  • POSITIVE

    Quarterly Net Profit Innospec Inc Jun-2026 Quarterly Net Profit is $31 Million which is growth of 31.1% YoY.

Innospec Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
491.4453.2455.6441.9439.7440.8466.8443.4435500.2494.7464.1480.4
Cost Of Rev.
353.1329.7328.2325.2316.5315.7330.6319.3308.1344.5339326.9330
Gross Profit
138.3123.5127.4116.7123.2125.1136.2124.1126.9155.7155.7137.2150.4
⌄
98.591.780.385.688.28293.877.985.6104.5111.295.3116.2
Operating Profit
39.831.847.131.13543.142.446.241.351.244.541.934.2
0.80.81.92.22.72.42.42.72.12.11.50.8-0.3
Profit Before Tax
41.639.950.311.531.944.4-102.644.843.755.345.347.536.6
Tax
10.49.12.9-1.48.411.6-32.211.412.513.97.58.37.7
⌄
30.830.447.412.923.532.8-70.433.431.241.437.839.228.9
Diluted NI Avail to Com Stockholders Ann.
30.830.447.412.923.532.8-70.433.431.241.437.839.228.9
Basic EPS
1.31.21.90.50.91.3-2.81.31.31.71.51.61.2
Diluted EPS After ExtraOrdinary
1.31.11.51.11.31.41.41.41.41.81.81.61.3
Number Of Shares End
24.624.824.824.824.9252524.924.924.924.924.924.9
Net Income Continuing Discontinued Operations
30.830.447.412.923.532.8-70.433.431.241.437.839.228.9
Normalized Income
31.526.337.22831.735.535.534.234.944.146.139.732.1
Interest Income
0.80.8-2.2---------
Interest
------------0.3
Net Interest Income
0.80.81.92.22.72.42.42.72.12.11.50.8-0.3
EBIT
40.839.148.49.329.242-10542.141.653.243.846.736.9
EBITDA
50.84957.821.540.352.9-94.153.252.763.65456.646.8
Reconciled Cost Of Rev.
353.1329.7328.2325.2316.5315.7330.6319.3308.1344.5339326.9330
Reconciled Depr.
109.99.412.211.110.910.911.111.110.410.29.99.9
Profit From Continuing Operations
31.630.447.412.923.532.8-70.433.431.241.437.839.228.9
Normalized EBITDA
49.934.354.165.251.554.2202.162.253.761.357.148.845.8
*All financials are in USD Million and price data in USD

Innospec Inc competitor comparison and performance snapshot within industry

Innospec Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEGATIVE

    Annual Revenue Innospec Inc Dec-2025 Annual Revenue is $1,778 Million which is growth of -3.7% YoY.

  • POSITIVE

    Annual Net Profit Innospec Inc Dec-2025 Annual Net Profit is $117 Million which is growth of 227.5% YoY.

Innospec Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-3.3%
8.3%
 1,7781,845.41,948.81,963.71,483.41,193.11,513.31,476.91,306.8883.41,012.3
Cost Of Rev. Ann.
-2.3%
8.6%
1,336.21,285.61,302.51,357.71,3771,048.5850.41,047.11,041.9903.5551.1666.3
Gross Profit Ann.
-5.7%
7.5%
505.9492.4542.9591.1586.7434.9342.7466.2435403.3332.3346
Operating Exp. Ann.
-5.6%
4.6%
356.1336.1361.8429.5399.4304.6267.9316.3294.4270.9234.9232
Operating Profit Ann.
-5.9%
15.9%
149.8156.3181.1161.6187.3130.374.8149.9140.6132.497.4114
-
-
5.79.29.32.3-1.1-1.5-1.8-4.8-6.9-8.2-3.2-4
Other Exp. Ann.
-
-
 -27.4-149.210.5-1.65.6-33.35.3-2.13.98.942.3
PBT Ann.
-9.2%
28.3%
143.3138.141.2174.4184.6134.439.7150.4131.6128.1103.1152.3
Tax Ann.
-25.3%
14.3%
2121.55.635.351.641.31138.246.666.321.832.8
⌄
-4.3%
32.4%
121.5116.635.6139.113393.128.7112.28561.881.3119.5
Diluted NI Avail to Com Stockholders Ann.
-4.3%
32.4%
121.5116.635.6139.113393.128.7112.28561.881.3119.5
EPS Ann.
-4.5%
31.4%
 4.71.45.65.43.81.24.63.52.63.45
Diluted EPS Ann.
-3.9%
31.4%
 4.71.45.65.33.81.24.53.52.53.34.9
Number Of Shares End
0%
0.2%
 24.82524.924.824.724.624.524.424.22423.9
Total Exp. Ann.
-3%
7.7%
 1,621.71,664.31,787.21,776.41,353.11,118.31,363.41,336.31,174.4786898.3
Net Income Continuing Discontinued Operations Ann.
-4.3%
32.4%
121.5116.635.6139.113393.128.7112.28561.881.3119.5
Normalized Income Ann.
-4.4%
10.6%
123132148.4152.4151119.379.7129118.9114.393.1107.1
Interest Income Ann.
-
-
 -----------
Interest Ann.
-
-
 ---1.11.51.84.86.98.23.24
EBITDA Ann.
-8.6%
14.5%
179.1172.575.5211.4225.8178.687.5202.8188.1186.7144.4191.5
Reconciled Cost Of Rev. Ann.
-2.3%
8.6%
1,336.21,285.61,302.51,357.71,3771,048.5850.41,047.11,041.9903.5551.1666.3
Reconciled Depr. Ann.
2.8%
-1.1%
41.543.643.539.340.142.74647.649.650.438.135.2
Profit From Continuing Operations Ann.
-4.3%
32.4%
122.3116.635.6139.113393.128.7112.28561.881.3119.5
Normalized EBITDA Ann.
-1%
11.8%
203.5225378.5197.3232.2178.4128.6202.8195.2189.4136.4149.2
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
-3.7%
2Y CAGR
-4.5%
3Y CAGR
-3.3%
5Y CAGR
8.3%
7Y CAGR
2.7%
10Y CAGR
5.8%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
227.5%
2Y CAGR
-8.4%
3Y CAGR
-4.3%
5Y CAGR
32.4%
7Y CAGR
4.6%
10Y CAGR
-0.2%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
-7.1%
2Y CAGR
-11.5%
3Y CAGR
-5.6%
5Y CAGR
4.6%
7Y CAGR
1.9%
10Y CAGR
3.8%
Operating Expenses Annual Cr is falling faster than historical averages.

Innospec Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Innospec Inc Dec-2025 Total Shareholders Fund is $1,326 Million which is growth of 9.5% YoY.

  • POSITIVE

    Total Assets Innospec Inc Dec-2025 Total Assets is $1,832 Million which is growth of 5.6% YoY.

Innospec Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
4.5%
5.6%
1,832.41,734.71,707.41,603.71,570.91,397.41,468.81,473.41,410.21,181.41,030
⌄
-3.9%
2%
499.5518.6557.8563.3537.9452.5549.9647.9615.9527.6424.7
⌄
8.5%
7%
1,326.11,211.21,147.11,0381,032.4944.4918.5825793.9653.5605
Total Capitalization Ann.
8.5%
7%
1,326.11,211.21,147.11,0381,032.4944.4977.11,011.2996.5912738
Tangible Assets Ann.
10.7%
11.5%
859.4763.3690.5634.2610.6497.9442323.8268.8134.3168.9
Working Capital Ann.
11.4%
15.5%
644.5585.2514.2466.8391.5313.8326.8367.3299.9258252.6
Invested Capital Ann.
8.5%
7%
1,326.11,211.21,147.11,0381,032.4944.4977.11,032.61,012.3922.3738
Tangible Book Value Ann.
10.7%
11.5%
859.4763.3690.5634.2610.6497.9442323.8268.8134.3168.9
Borrowings Ann.
5.2%
5.3%
52.744.945.245.335.640.892.6210.9224.3273.3136.1
Net Debt Ann.
-
-
-------84.5128.2166.9-
Share Issued Ann.
0%
0%
29.629.629.629.629.629.629.629.629.629.629.6
Number Of Shares End
0%
0.2%
24.82524.924.824.724.624.524.424.22423.9
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
5.6%
2Y CAGR
3.6%
3Y CAGR
4.5%
5Y CAGR
5.6%
7Y CAGR
3.2%
10Y CAGR
5.9%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-3%
2Y CAGR
-1.5%
3Y CAGR
-3.9%
5Y CAGR
7.4%
7Y CAGR
2.8%
10Y CAGR
5.7%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
9.5%
2Y CAGR
7.5%
3Y CAGR
8.5%
5Y CAGR
7%
7Y CAGR
7%
10Y CAGR
8.2%
Total ShareHolders Funds Annual growth is higher than historical averages.

Innospec Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share Innospec Inc Book Value Per Share is $54 which is growth of 10.3% YoY.

  • NEUTRAL

    ROE Innospec Inc ROE is 0% which is growth of 0% YoY.

Innospec Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-2.07%8.40%8.38%6.27%2.00%7.63%5.90%4.77%7.35%11.77%
ROE Ann. %
-
-
-3.02%12.73%12.85%9.42%3.08%12.87%10.50%8.54%12.92%21.32%
ROIC %
-
-
--5.53.22.32.32.43.12.1-0.42.74.4
OPM Ann. %
-2.7%
7%
8.79%9.81%8.29%9.54%8.78%6.27%9.91%9.52%10.13%11.03%11.26%
Inventory Turnover Ratio Ann.
-
-
-4.344.24.23.74.34.64.73.33.9
Asset Turnover Ann. %
-
-
-1.11.21.210.81110.81
Working Capital Turnover Ann.
-12.6%
-5.9%
2.83.23.84.23.83.84.644.43.44
Quick Ratio Ann.
-
-
-1.71.51.21.31.31.21.41.31.41.4
Current Ratio Ann.
-
-
-2.62.42.22.22.22.12.22.22.42.2
Interest Coverage Ratio Ann.
-
-
---168.890.623.132.320.116.633.239.1
LT Debt To Equity Ann.
-
-
-000000.10.20.30.40.2
*All financials are in USD Million and price data in USD

Innospec Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Innospec Inc Dec-2025 Cash From Operating Activity is $138 Million which is growth of -25.0% YoY.

  • NEGATIVE

    Net Cash Flow Innospec Inc Dec-2025 Net Cash Flow is $-1 Million which is growth of -100.8% YoY.

Innospec Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
19.2%
-1.1%
138.3184.5207.381.793.2145.9161.6104.982.7104.5117.7
-
-
-75.1-62-111.8-42.1-36.2-29.7-31-35.5-29.6-209.115
-
-
-63.9-35.3-39-33.7-20-86.8-177.9-36.2-66.470.5-36.3
Cash Plus Cash Eqv. End Of Year Ann.
25.7%
22.7%
292.5289.2203.7147.1141.8105.375.7123.190.2101.9136.9
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-0.787.256.55.93729.4-47.333.2-13.3-34.196.4
Cash Plus Cash Eqv. Begin Of Year Ann.
26.8%
30.7%
289.2203.7147.1141.8105.375.7123.190.2101.9136.941.6
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
-75.5-62.3-77.2-42.3-39.1-29.7-31-30.1-32.2-16.5-26.2
Issuance Of Capital Stock Ann.
-39%
-25.6%
0.52.10.92.210.12.21.21.16.82.11
Issuance Of Debt Ann.
-
-
--15105.510101586
Repayment Of Debt Ann.
-
-
-2.3-0.1-0.6-76.1-255.7-24.2-63.5-21.1-12.4
Repurchase Of Capital Stock Ann.
-
-
-23.9-0.7-1.1-5.9-0.8-2.1-2.4-1.4-1.1-8.4-15.3
Free Cash Flow Ann.
16.8%
-11.6%
62.8122.2130.139.454.1116.2130.674.850.58891.5
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
-25%
2Y CAGR
-18.3%
3Y CAGR
19.2%
5Y CAGR
-1.1%
7Y CAGR
4%
10Y CAGR
1.6%
Cash from Operating Activity Annual is falling faster than historical averages.